Grant: Engage Grants Program
École Polytechnique de Montréal
$25,000.00
Dymedso FrequencerTM Technology Optimization
FY 2017-18
Summary
Dymedso Company has been working for several years in the research and development of new medicaltechnology, The FrequencerTM, to help patients affected by chronic respiratory diseases (CRDs) related todefective mucociliary clearance including cystic fibrosis (CF) and chronic bronchitis, among others.The FrequencerTM, manufactured by Dymedso Company, is a digitally controlled acoustic airway clearancepoint-of-care (POC) device that promotes bronchial drainage by inducing vibrations in the chest wall of thepatient. The FrequencerTM provides a gentler and less painful form of therapy than the traditional ""clappingmethod"" or postural drainage. The current and older versions of this device have received certifications fromHealth Canada, FDA, ISO 13485:2003, and UL for North America, Europe, Australia and New Zealand.Dymedso is planning to introduce a new technology of its sound-wave generation therapy that addresses someissues identified by patients and caregivers over the past years of use in clinical practice. The identified issuesinvolve ergonomic and performance limitations. For instance, the current version of the device is stillcumbersome for patient use. Thus, for more practical and effective use, the device needs to be optimized interms of size, weight, and overall performance. We will carefully analyze each of the modules composing TheFrequencerTM including the sound-wave generator, the transducer, and the communication system to proposeimprovements for each of them. In addition, different types of sensors and feedback interfaces will beinvestigated for the new version in order to improve the effectiveness of this device.
Program
Engage Grants Program
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
520294-2017
Name nom
Sawan, Mohamad
Department département
Génie électrique
Organization id
64
Institution établissement
École Polytechnique de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
2500
Research subject group en
Electrical and electronic engineering
Research subject group fr
Génie électrique et électronique
Research subject en
Electrical and electronic engineering
Research subject fr
Génie électrique et électronique
Partie
1
Nb partie
1
Application title
Dymedso FrequencerTM Technology Optimization
Keyword
NSERC
Application summary
Dymedso Company has been working for several years in the research and development of new medicaltechnology, The FrequencerTM, to help patients affected by chronic respiratory diseases (CRDs) related todefective mucociliary clearance including cystic fibrosis (CF) and chronic bronchitis, among others.The FrequencerTM, manufactured by Dymedso Company, is a digitally controlled acoustic airway clearancepoint-of-care (POC) device that promotes bronchial drainage by inducing vibrations in the chest wall of thepatient. The FrequencerTM provides a gentler and less painful form of therapy than the traditional ""clappingmethod"" or postural drainage. The current and older versions of this device have received certifications fromHealth Canada, FDA, ISO 13485:2003, and UL for North America, Europe, Australia and New Zealand.Dymedso is planning to introduce a new technology of its sound-wave generation therapy that addresses someissues identified by patients and caregivers over the past years of use in clinical practice. The identified issuesinvolve ergonomic and performance limitations. For instance, the current version of the device is stillcumbersome for patient use. Thus, for more practical and effective use, the device needs to be optimized interms of size, weight, and overall performance. We will carefully analyze each of the modules composing TheFrequencerTM including the sound-wave generator, the transducer, and the communication system to proposeimprovements for each of them. In addition, different types of sensors and feedback interfaces will beinvestigated for the new version in order to improve the effectiveness of this device.